ANTI-INFECTIVE PYRIMIDINES AND USES THEREOF

The present invention relates to a crystalline form of N-(6-(3-tert-butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl)naphthalen-2-yl)methanesulfonamide or a crystalline form of a salt of N-(6-(3-tert-butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl)naphthalen-2-yl)m...

Full description

Saved in:
Bibliographic Details
Main Authors BARNES, DAVID, M, STEWART, KENT, D, HUTCHINSON, DOUGLAS, K, KATI, WARREN, M, ROCKWAY, TODD, W, KRUEGER, ALLAN, C, LIU, DACHUN, WAGNER, ROLF, FRANCZYK, THADDEUS, S., II, MARING, CLARENCE, J, CHEN, SHUANG, DONNER, PAMELA, L, MOTTER, CHRISTOPHER, E, LONGENECKER, KENTON, L, FLENTGE, CHARLES, A, DEGOEY, DAVID, A, PRATT, JOHN, K, RANDOLPH, JOHN, T, BETEBENNER, DAVID, A, LIU, YAYA
Format Patent
LanguageEnglish
French
German
Published 10.08.2011
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to a crystalline form of N-(6-(3-tert-butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl)naphthalen-2-yl)methanesulfonamide or a crystalline form of a salt of N-(6-(3-tert-butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl)naphthalen-2-yl)methanesulfonamide as well as pharmaceutical compositions comprising said crystalline forms, therapeutic uses of said crystalline forms and processes for making said crystalline forms.
Bibliography:Application Number: EP20080832330